iRegene Therapeutics
Suzhou, China· Est.
iRegene Therapeutics focuses on developing cell and gene therapies for ophthalmic and neurodegenerative diseases.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
About
iRegene Therapeutics focuses on developing cell and gene therapies for ophthalmic and neurodegenerative diseases.
Cell TherapyGene TherapyOphthalmology